期刊文献+

抗肿瘤坏死因子抗体对大鼠急性出血坏死性胰腺炎的治疗作用 被引量:5

THERAPEUTIC ROLE OF ANTI TNFα ANTIBODY AGAINST ACUTE HEMOERRHAGIC AND NECROTIZING PANCREATITIS IN RATS
全文增补中
导出
摘要 采用牛磺胆酸钠复制大鼠急性出血坏死性胰腺炎(AHNP)模型,动态观察其血浆肿瘤坏死因子α(TNFα)含量、血清脂肪酶含量和胰腺病理改变等,以及抗肿瘤坏死因子α单克隆抗体(TNFαMCAb)的治疗对它们的作用,并与假手术组比较。结果显示:假手术组大鼠的各项检测指标无异常改变,无动物死亡。AHNP组腹水量、血清脂肪酶及血浆TNFα水平均较假手术组显著增加,胰腺病理改变明显;经TNFαMCAb治疗后,血浆TNFα水平未见升高,而血清脂肪酶下降,腹水积聚减少,胰腺病理改变减轻,动物死亡率显著下降。由此提示,TNFα在AHNP发病机理中起重要作用。 Acute hemorrhagic and necrotizing pancreatitis (AHNP) was induced by injection of sodium taurocholate into pancreatic and biliary duct of rats. TNFα MCAb was infused intravenously 15 minutes before pancreatitis was induced, and plasm TNFα level, serum lipase level and pancratic pathologic changes were tested.Results: the amount of ascites, serum lipase level and palsm TNFα level were significantly incresed and severe pancreatic pathologic changes was induced after AHNP, as compared with those in the control group .However, plasm TNFα level was not elevated after administration of TNFα MCAb, and the amount of ascites and pathologic damage to the pancreas were markely reduced. The animal fatality was reduced too. Conclusions: these suggest that TNFα play an important role in the pathogenesis of AHNP, and TNFα MCAb have a certain therapeutic effect on AHNP in rats.
出处 《中国普外基础与临床杂志》 CAS 1999年第1期15-17,共3页 Chinese Journal of Bases and Clinics In General Surgery
关键词 出血坏死性 胰腺炎 肿瘤坏死因子 单克隆抗体 Rat Acute hemorrhagic and necrotizing pancreatitis Tumor necrosis factor α monoclonal antibody
  • 相关文献

同被引文献32

  • 1中华医学会消化病学分会胰腺疾病学组.中国急性胰腺炎诊治指南(草案)[J].解放军医学杂志,2004,29(7):646-648. 被引量:91
  • 2庄岩,杨尹默,王维民,万远廉,黄延庭.急性胰腺炎鼠白细胞介素(IL)1β、IL-18、肿瘤坏死因子α、IL-1β转化酶的表达[J].中华实验外科杂志,2005,22(1):71-72. 被引量:34
  • 3查艳,周力,刘琦,张永宏,马启玲.反复短时血滤疗法对重症急性胰腺炎细胞因子的影响[J].贵阳医学院学报,2005,30(1):36-38. 被引量:8
  • 4胡森,盛志勇,薛立波,周宝桐,陆江阳,晋桦,于燕,孙晓床,黎君友,郑玉清,熊德鑫.多器官功能障碍综合征动物模型的系列研究[J].解放军医学杂志,1996,21(1):5-9. 被引量:57
  • 5Bhatia M, Neoptolemos JP, Slavin J. Inflammatory mediators as therapeutic targets in acute pancreatitis [ J ] . Curr Opin Investig Drugs, 2001, 2 (4) : 496-501.
  • 6Oruc N, Ozutemiz AO, Yukselen V, et al. Infliximab: A new therapeutic agent in acute pancreatitis? [ J] . Pancreas, 2004, 28 ( 1 ) : 1-8.
  • 7Fantini L, Tomassetti P, Pezzilli R. Management of acute pancreatitis: current knowledge and future perspectives [J] . World J Emerg Surg, 2006, 23 (1) : 16.
  • 8Triantafinidis JK, Cheracakis P, Hereti IA, et al. Acute idiopathic pancreatitis complicating active Crohn' s disease: favorable response to infliximab treatment [ J ] . Am J Gastroenterol, 2000, 95 (11) : 3334-3336.
  • 9Mews P, Philips P, Fahmy R, et al. Pancreatic stellate cells respond to inflammatory cytokines: potential role in chronic pancreatitis. Gut, 2002,50:535- 542.
  • 10Shields CJ,Winter DC,Redmond HP. Lung injury in acute pancreatitis:mechanisms, prevention and therapy. Curr Opin Crit Care, 2001,8 (2):158- 163.

引证文献5

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部